ISPC · iSpecimen Inc.
$0.94
+0.03 (+3.38%)
At close · Oct 20
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year from the date these unaudited condensed financial statements are issued. Management's plan to mitigate the conditions that raise substantial doubt includes generating additional revenues, deferring certain projects and capital expenditures and eliminating certain future operating expenses for the Company to continue as a going concern. However, there can be no assurance that the Company will be successful in completing any of these options. As a result, management's plans cannot be considered probable and thus do not alleviate substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$2.29M
Shares
2.52M
Volume · Oct 20
203.99K
Avg daily vol (3M)
658.71K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.91
Open$0.92
Day$0.90–0.96
52W close$0.91–34.40
Avg vol 30d818K
Short int161K · 6.4% float · 1.0d
Short vol42%
Last earningsAug 6, 2024
DataJun 2021–Oct 2026
Filing10-Q · Aug 14
Up next
filed Aug 14, 2026
call held Mar 14, 2024
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
$466,302
Trailing 12 months
Net income (TTM)
−$11.42M
Trailing 12 months
Revenue growth YoY
-78.7%
Year over year
Operating margin
-2,020.0%
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
$4.41M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+2,133.9%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
6.4%
Latest settlement · 1.0 days to cover
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Neutral
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 18.4 · elevated
Equity put/call 0.55
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−83%
below
Price vs 50-day avg
−39%
below
RSI (14)
23
oversold
MACD trend
Positive
52-week position
0%
near low
Volume (OBV)
Bullish div.
accumulating
Momentum
relative strength
1-month return
−31%
trailing
6-month return
−80%
trailing
YTD return
−91%
this year
Relative strength
−88%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-33% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.39% of float · ▼ -27.1% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
8 holders — mid 3-yr range
Squeeze score
39
low risk · 0–100
Fundamentals
Revenue growth
−79%
Y/Y
EPS growth
+87%
Y/Y
Free cash flow
$-4.2M
Balance sheet
$24.3M
net cash
Quant / Vol
risk profile
Volatility
113%
annualized · 1-yr
Max drawdown
−97%
past year
ATR
10.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−83%
Bearish
Price vs 50-day avg
−39%
Bearish
RSI (14)
23
Neutral
MACD trend
Positive
Bullish
52-week position
0%
Bearish
Volume (OBV)
Bullish div.
Bullish
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $5 — 200d above 50d
Institutional flow
Distributing
-33% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
6.39% of float · ▼ -27.1% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
8 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 0%
Range high $34
vs 200-day avg -83%
vs 50-day avg -39%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| average selling price per specimen | $454 | the three months ended June 30, 2026 filing | — |
| specimen count | 335 | the three months ended June 30, 2026 filing | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Diagnostics & Research — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ISPC
this stock
iSpecimen Inc.
|
$2.29M | — | -79.2% | — | 6.4% |
|
TMO
Thermo Fisher Scientific Inc.
|
$251.20B | +17.2% | +14.5% | 36.6 | 1.5% |
|
DHR
Danaher Corp /De/
|
$157.77B | -2.0% | +8.5% | 39.8 | 1.3% |
|
NTRA
Natera, Inc.
|
$57.57B | +74.4% | -2.8% | — | 4.4% |
|
A
Agilent Technologies, Inc.
|
$48.56B | +24.9% | +6.4% | 33.9 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
SEC Filings
Latest
DEFR14A
- Filed
- Oct 19, 2026
- This year
- 39
iSpecimen Inc. amended its proxy statement for the October 30, 2026 Adjourned Meeting to change Proposal No. 2's vote standard to a FOR-over-AGAINST majority under DGCL Section 242(d)(2) and allow broker discretionary voting on the Reverse Stock Split Proposal at a ratio of 1-for-10 to 1-for-100.
ViewEarnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ISPC | -15.7% | -31.1% | -80.0% | -22.9% | -91.3% |
| SPY | -1.5% | -0.9% | +7.7% | +0.5% | +12.4% |
| vs SPY | -14.2% | -30.1% | -87.7% | -23.4% | -103.7% |